CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Stockholders’ (Deficit) Equity	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Treasury stock, at cost	Non-controlling interest
Balance at Dec. 31, 2021	$ 99,442	$ 99,442	$ 11	$ 747,928	$ (648,376)	$ (121)
Balance (in Shares) at Dec. 31, 2021			96,546,611
Increase (Decrease) in Stockholders' Equity
Exercise of common stock options	26	26		26
Exercise of common stock options (in Shares)			7,325
Exercise of common warrants (in Shares)			10
Stock-based compensation expense	7,195	7,195		7,195
Net income (loss)	(9,711)	(9,711)			(9,711)
Foreign currency translation adjustment	(13)	(13)				(13)
Common stock received for tax withholding	(1)	(1)					(1)
Common stock received for tax withholding (in Shares)			(173)
Balance at Mar. 31, 2022	96,938	96,938	$ 11	755,149	(658,087)	(134)	(1)
Balance (in Shares) at Mar. 31, 2022			96,553,773
Balance at Dec. 31, 2021	99,442	99,442	$ 11	747,928	(648,376)	(121)
Balance (in Shares) at Dec. 31, 2021			96,546,611
Increase (Decrease) in Stockholders' Equity
Net income (loss)	(27,614)
Foreign currency translation adjustment	(24)
Balance at Sep. 30, 2022	92,441	92,441	$ 11	768,569	(675,990)	(145)	(4)
Balance (in Shares) at Sep. 30, 2022			101,393,158
Balance at Mar. 31, 2022	96,938	96,938	$ 11	755,149	(658,087)	(134)	(1)
Balance (in Shares) at Mar. 31, 2022			96,553,773
Increase (Decrease) in Stockholders' Equity
Vesting of RSUs (in shares)			239,266
Issuance of RSAs (in shares)			205,850
Exercise of common stock options	22	22		22
Exercise of common stock options (in Shares)			79,614
Exercise of common warrants (in Shares)			4,308,297
Stock-based compensation expense	6,763	6,763		6,763
Net income (loss)	827	827			827
Foreign currency translation adjustment	(9)	(9)				(9)
Balance at Jun. 30, 2022	104,541	104,541		761,934	(657,260)	(143)	(1)
Balance (in Shares) at Jun. 30, 2022			101,386,800
Increase (Decrease) in Stockholders' Equity
Vesting of RSUs (in shares)			21,214
Issuance of RSAs (in shares)			43,430
Cancellation of RSAs (in Shares)			(57,282)
Stock-based compensation expense	6,635	6,635		6,635
Net income (loss)	(18,730)	(18,730)			(18,730)
Foreign currency translation adjustment	(2)	(2)				(2)
Common stock received for tax withholding	(3)	(3)					(3)
Common stock received for tax withholding (in Shares)			(1,004)
Balance at Sep. 30, 2022	92,441	92,441	$ 11	768,569	(675,990)	(145)	(4)
Balance (in Shares) at Sep. 30, 2022			101,393,158
Balance at Dec. 31, 2022	103,864	100,017	$ 12	787,130	(688,492)	1,371	(4)	3,847
Balance (in Shares) at Dec. 31, 2022			106,417,265
Increase (Decrease) in Stockholders' Equity
Vesting of RSUs (in shares)			619,387
Issuance of RSAs (in shares)			27,744
Exercise of common stock options	25	25		25
Exercise of common stock options (in Shares)			91,258
Stock-based compensation expense	4,548	4,548		4,548
Net income (loss)	(16,349)	(16,349)			(16,349)
Foreign currency translation adjustment	432	432				432
Balance at Mar. 31, 2023	92,520	88,673	$ 12	791,703	(704,841)	1,803	(4)	3,847
Balance (in Shares) at Mar. 31, 2023			107,155,654
Balance at Dec. 31, 2022	103,864	100,017	$ 12	787,130	(688,492)	1,371	(4)	3,847
Balance (in Shares) at Dec. 31, 2022			106,417,265
Increase (Decrease) in Stockholders' Equity
Net income (loss)	(55,339)
Foreign currency translation adjustment	(218)
Balance at Sep. 30, 2023	84,105	80,258	$ 12	822,928	(743,831)	1,153	(4)	3,847
Balance (in Shares) at Sep. 30, 2023			108,976,312
Balance at Mar. 31, 2023	92,520	88,673	$ 12	791,703	(704,841)	1,803	(4)	3,847
Balance (in Shares) at Mar. 31, 2023			107,155,654
Increase (Decrease) in Stockholders' Equity
Vesting of RSUs (in shares)			605,975
Issuance of RSAs (in shares)			376,325
Exercise of common stock options	13	13		13
Exercise of common stock options (in Shares)			46,583
Stock-based compensation expense	3,697	3,697		3,697
Issuance of common warrants	14,598	14,598		14,598
Net income (loss)	(15,770)	(15,770)			(15,770)
Foreign currency translation adjustment	20	20				20
Balance at Jun. 30, 2023	95,078	91,231	$ 12	810,011	(720,611)	1,823	(4)	3,847
Balance (in Shares) at Jun. 30, 2023			108,184,537
Increase (Decrease) in Stockholders' Equity
Vesting of RSUs (in shares)			260,215
Issuance of RSAs (in shares)			24,500
Exercise of common stock options	28	28		28
Exercise of common stock options (in Shares)			98,829
Exercise of common warrants	882	882		882
Exercise of common warrants (in Shares)			408,231
Stock-based compensation expense	3,762	3,762		3,762
Issuance of common warrants	8,245	8,245		8,245
Net income (loss)	(23,220)	(23,220)			(23,220)
Foreign currency translation adjustment	(670)	(670)				(670)
Balance at Sep. 30, 2023	$ 84,105	$ 80,258	$ 12	$ 822,928	$ (743,831)	$ 1,153	$ (4)	$ 3,847
Balance (in Shares) at Sep. 30, 2023			108,976,312